Viozan

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Libraries of dibasic compounds designed around the molecular scaffold of the DA(2)/β(2) dual agonist sibenadet (Viozan™) have… (More)
  • figure 1
  • table 2
  • table 3
  • table 4
  • figure 2
Is this relevant?
2011
2011
Starting with the molecular scaffold of the DA(2)/β(2) dual agonist sibenadet (Viozan™), a number of molecular changes were… (More)
Is this relevant?
2007
2007
Viozan TM (sibenadet HCI,AR-C68397AA) is a novel dual D 2 dopamine receptor, 132-adrenoceptor agonist that has been investigated… (More)
  • figure I
  • table 5
Is this relevant?
2003
2003
Viozan (sibenadet HCl, AR-C68397AA) is a novel dual D2 dopamine receptor, beta2-adrenoceptor agonist that has been investigated… (More)
Is this relevant?
2003
2003
Viozan (sibenadet HCl, AR-C68397AA) is a novel dual D2 dopamine receptor, beta2-adrenoceptor agonist, developed specifically to… (More)
  • figure I
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2003
2003
The development of novel drugs for the treatment of chronic obstructive pulmonary disease (COPD) poses significant challenges… (More)
Is this relevant?
2003
2003
Viozan, (Sibenadet HCl, AR-C68397AA) is a dual D2 dopamine receptor, beta2-adrenoceptor agonist that combines bronchodilator… (More)
Is this relevant?
2003
2003
In order to identify healthcare resource use patterns associated with chronic obstructive pulmonary disease (COPD), resource… (More)
Is this relevant?
2002
2002
Sensory nerves regulate central and local reflexes such as airway plasma leakage, and cough and their function may be enhanced… (More)
Is this relevant?
2001
2001
The mechanism by which 2(3H)-benzothiazolone, 4-hydroxy-7-[2-[[2-[[3-(2-phenylethoxy)propyl]sulphonyl]ethyl]amino]ethyl… (More)
Is this relevant?